Indefinite Self-Renewal of ESCs through Myc/Max Transcriptional Complex-Independent Mechanisms  by Hishida, Tomoaki et al.
Cell Stem Cell
ArticleIndefinite Self-Renewal of ESCs through Myc/Max
Transcriptional Complex-Independent Mechanisms
Tomoaki Hishida,1,4 Yuriko Nozaki,1,4 Yutaka Nakachi,2 Yosuke Mizuno,2 Yasushi Okazaki,2,4 Masatsugu Ema,5,6
Satoru Takahashi,4,6 Masazumi Nishimoto,3 and Akihiko Okuda1,4,*
1Division of Developmental Biology
2Division of Functional Genomics and Systems Medicine
3Radioisotope Experimental Laboratory
Research Center for Genomic Medicine, Saitama Medical University, Yamane Hidaka, Saitama 350-1241, Japan
4Core Research for Evolutional Science and Technology (CREST)
5Precursory Research for Embryonic Science and Technology (PRESTO)
Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
6Department of Anatomy and Embryology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences,
University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan
*Correspondence: akiokuda@saitama-med.ac.jp
DOI 10.1016/j.stem.2011.04.020SUMMARY
Embryonic stem cells (ESCs) can self-renew indefi-
nitely under the governance of ESC-specific tran-
scriptional circuitries in which each transcriptional
factor regulates distinct or overlapping sets of genes
with other factors. c-Myc is a key player that is
crucially involved in maintaining the undifferentiated
state and the self-renewal of ESCs. However, the
mechanism by which c-Myc helps preserve the
ESC status is still poorly understood. Here we ad-
dressed this question by performing loss-of-function
studies with the Max gene, which encodes the best-
characterized partner protein for all Myc family
proteins. Although Myc/Max complexes are widely
regarded as crucial regulators of the ESC status,
our data revealed that ESCsdo not absolutely require
these complexes in certain contexts and that this
requirement is restricted to empirical ESC culture
conditions without a MAPK inhibitor.
INTRODUCTION
ESCs are defined by their pluripotency and unlimited self-
renewal (Nichols and Smith, 2009; Niwa, 2007; Rossant, 2008).
These characteristics are sustained by numerous signal trans-
duction pathways, including pathways that involve leukemia
inhibitory factor (LIF) and bone morphogenic protein, and tran-
scription factors including Oct3/4, Sox2, and Nanog (see Silva
andSmith, 2008, and references therein). The transcription factor
c-Myc is critically involved in maintaining the pluripotency and
self-renewing properties of ESCs (Cartwright et al., 2005; Singh
and Dalton, 2009). Accumulating evidence suggests that the
function of c-Myc in ESCs is largely independent of the Oct3/4,
Sox2, and Nanog networks (Hu et al., 2009; Kim et al., 2010).
Recent studies with c-Myc/N-Myc double-knockout (dKO)
ESCs demonstrate that c-Myc and N-Myc, which have highlyredundant functions, are required to maintain ESC self-renewal
and pluripotency (Smith et al., 2010; Varlakhanova et al., 2010).
Moreover, an examination of Myc molecular function in ESCs
showed that the protein sustains pluripotency by repressing
gene expression of the primitive endoderm master regulator
Gata6. In addition, the Myc protein helps control the cell cycle
by regulating the mir-17-92 miRNA cluster (Smith et al., 2010).
However, there are numerous unanswered questions about the
roles of c-Myc in ESCs. For example, it is unknownwhether there
is a situation in ESCs in which Myc function may be redundant.
In this report, we demonstrate that ablatingMax gene expres-
sion in ESCs, which encodes the best-characterized partner
protein for c-Myc, N-Myc, and L-Myc proteins (Blackwood
et al., 1992; Shen-Li et al., 2000), leads to a loss of the undiffer-
entiated state and extensive cell death. Interestingly, these two
phenomena occur in a compulsory order with the loss of the
undifferentiated state occurring first, indicating that undifferenti-
ated ESCs fail to execute the cell death program. More impor-
tantly, we provide evidence that the newly established ESC
culture conditions by using MAPK and GSK3b inhibitors (Ying
et al., 2008) render the c-Myc/Max complex dispensable. This
indicates that ESCs are not necessarily dependent on the c-
Myc/Max complex to preserve their prominent features and
that this requirement is context dependent.RESULTS
Myc/Max Complexes Are Required for ESC
Self-Renewal and Cell Viability
To determine the molecular basis of the ESC-specific function of
Myc, we generated Max-null ESCs in which both alleles of the
Max gene are disrupted and Max cDNA was introduced into
the ROSA26 locus under the control of a tetracycline (tet)-off
system (see Supplemental Experimental Procedures and
Figures S1A–S1D; Masui et al., 2005). As depicted in Figure 1A,
these Max-null ESCs did not express the Max gene in the pres-
ence of doxycycline (Dox), although the absence of Dox induced
Max expression. We confirmed that both the Max mRNA and
protein levels were rapidly downregulated by Dox addition toCell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc. 37
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Figure 1. Myc/Max Complexes Have a Critical Role in ESC Viability
(A) Schematic representation of Max-null ESCs. Max and Venus from the ROSA26 locus are expressed under the control of a tet-off system.
(B) Analyses of Max, c-Myc, N-Myc, and L-Myc protein levels after ablating Max expression.
(C) Viability examination of Dox-untreated and -treated Max-null ESCs. Viability was examined 12 days after seeding Max-null ESCs at a clonal density.
(D) Microscopy examination of ESCs after ablating Max expression.
(E) Cell cycle analysis of Max-null ESCs by FACS. The data represent the mean with standard deviation (n = 3).
(F) Detection of cleaved Cas-3 in Max-null ESCs.
(G) Effect of Z-VAD-FMK on Max-null ESC apoptosis. Max-null ESCs were either untreated or treated with Z-VAD-FMK for 6 days in the presence of Dox.
(H) Schematic representation of the EG and RX mutants of c-Myc and Max proteins. In the EG mutants, the amino acids in c-Myc and Max involved in their
interaction are reciprocally exchanged (Amati et al., 1993).
(I) Rescue by c-Myc/Maxmutant pairs. After stably introducing expression vectors encoding wild-type (WT) or the EG/RXmutants of c-Myc and/or Max,Max-null
ESCs were treated with Dox for 6 days. The rescue index represents the relative number of colonies obtained in the absence of Dox. The data represent themean
with standard deviation (n = 3).
See also Figure S1.
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Myc/Max Complex-Independent ESC Self-Renewalthe culture medium (Figures 1B and 3A). We also found that the
protein levels of c-Myc, N-Myc, and L-Myc significantly
decreased during the course of Dox-induced repression of
Max protein expression (Figure 1B). This was consistent with
a previous report that demonstrated free Myc proteins that are38 Cell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc.not associated with Max are more unstable than the proteins
complexed with Max (Blackwood et al., 1992).
To examine the effect of ablation of Max gene expression on
cell viability, Max-null ESCs were seeded at a clonal density,
treated with Dox for 12 days, and then stained with Leishman’s
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Myc/Max Complex-Independent ESC Self-Renewalstain. The Dox-treated cells did not form colonies, although the
untreated cells formed robust colonies (Figure 1C). Moreover,
microscopy examination ofMax-null ESCs at various time points
after Dox treatment revealed an abnormal morphology and
severely impaired growth (Figure 1D). Cell cycle analyses indi-
cated that ablation of Max gene expression led to a reduction
in proliferation and cells with a sub-G1-phase that most probably
reflected apoptosis (Figure 1E). Apoptotic cell death was also
indicated by a TdT-mediated dUTP-biotin nick end-labeling
(TUNEL) assay (Figure S1E) and the detection of cleaved acti-
vated caspase-3 (Cas-3) (Figure 1F). Treating with Z-VAD-
FMK, a pan-caspase inhibitor, eliminated the appearance of
TUNEL-positive cells (Figure 1G), indicating that caspase activa-
tion is responsible for the death of Max-null ESCs.
Max interacts not only with Myc family proteins but also with
Mad family proteins that are natural Myc antagonists (Baudino
and Cleveland, 2001). Moreover, some Mad family proteins,
such as Mad3 and Mxi1, are highly expressed in ESCs (data not
shown). Therefore, there is the possibility that functional inactiva-
tion of Mad family proteins, but not c-Myc family proteins, is the
major cause of the lethal phenotype observed in Max-null
ESCs. To examine this, we used the Max and Myc mutants
depicted in Figure 1H, which were generated by Amati et al.
(1993). These mutants were constructed either by exchanging
the helix-loop-helix-leucine zipper (HLH-Z) domains (RX mutant)
or reciprocallymodifying the leucine zipper dimerization specific-
ities (EG mutant; for details, see Amati et al., 1993). The RX
mutants (also true for EG mutants) did not bind to their endoge-
nous partners, but efficiently dimerized with each other. This
was further confirmed by coimmunoprecipitation analyses (data
not shown). We performed rescue experiments by stably trans-
fecting Max-null ESCs with the expression plasmids. As ex-
pected, overexpressing wild-type Max alone led to efficient
colony formation. For the EG and RXmutants, an equivalent level
of efficiency was obtained only when a Max mutant (EG or RX)
was introduced together with the reciprocal c-Myc mutant (Fig-
ure 1I). We observed weak activity when the Max EG mutant
was expressed alone. We assumed that this activity indicated
a partial preservation of the ability to interact with the wild-type
c-Myc protein, as was previously reported (Amati et al., 1993).
These results allowed us to conclude that the lack of functional
Myc/Max complexes, but not Mad/Max complexes, is respon-
sible for the detrimental phenotype of Max-null ESCs. It should
be noted that, unlike loss ofMax gene expression, simultaneous
loss of c-Myc and N-Myc gene expression insignificantly im-
pacted cell viability (Smith et al., 2010; Varlakhanova et al.,
2010). Although we do not currently know why this happened,
there are several possibilities that may explain these phenotypic
differences (see Discussion).
A recent report with a chemical inhibitor (10058-F4) that
disrupts the interaction between c-Myc and Max revealed that
the complex augments gene expression by releasing RNA poly-
merase II (Pol II) around the gene promoter region rather than
recruiting Pol II to the targeted gene (Rahl et al., 2010). Therefore,
we examinedwhether Pol II is paused around the promoter-prox-
imal gene regions inMax-null ESCs. This can be assessed by the
positions of phosphorylation sites within the C-terminal domain
(CTD) of the largest Pol II subunit. Although we confirmed the
previously reported result by means of 10058-F4, no decline inthe level of Pol II engaged in transcription elongation was evident
in Dox-treatedMax-null ESCs. This was indicated by the level of
serine2phosphorylation in theCTD,which isdirectly proportional
to the level of Pol II released from promoter proximal pausing
(Figures S1F and S1G). We assumed that this discrepancy was
due to the difference in rapidness of eliminating the interaction
between c-Myc and Max. Approximately 2 days was required
for complete Dox-mediated elimination of the Max protein and
thismay be long enough to execute a presently unknown alterna-
tive mechanism of Pol II release from gene promoters.
Alterations in Gene Expression after AblatingMax Gene
Expression
Apoptosis observed with c-Myc/N-Myc dKO hematopoietic stem
cells (HSCs) is mediated by upregulatedGrazyme B gene expres-
sion (Laurenti et al., 2008). We examined expression of this gene
and other related genes such as Granzyme A in Max-null ESCs.
However, we found that these genes were not expressed in the
cells, irrespective of treatment with Dox (data not shown). To
explore the molecular basis of apoptosis and other phenotypes
observed inMax-null ESCs, we performed DNA microarray anal-
yses. First, we compared the gene expression betweenMax-null
ESCs and c-Myc/N-Myc dKO HSCs. However, we did not find
any obvious tendency that the genes regulated differentially in
dKO HSCs compared with those in wild-type HSCs (Laurenti
et al., 2008) altered their expression levels in a similar trend in
Max-null ESCs (Figures S2A and S2B), indicating that gene sets
regulated by Myc/Max complexes are rather different between
ESCs andHSCs. As anext step, the geneswith altered expression
levels more than 2-fold (upregulated genes, 1696; downregulated
genes, 1402) in Max-null ESCs were assigned to gene ontology
(GO) classification to correlate gene expression changes with
overall molecular functions. GO terms that were significantly en-
riched among the upregulated or downregulated genes are shown
(Table S1). Among these GO terms, wewere especially interested
in a gene set associatedwith antioxidant activity because reactive
oxygen species (ROS) can induce apoptosis and c-Myc is re-
ported to suppress ROS levels (Benassi et al., 2006; Esteban
et al., 2010). Gene set enrichment analysis (GSEA) (Subramanian
etal., 2005) of genescomprising thisGOtermshowedaprominent
decrease in activity after ablation ofMax gene expression, which
was not seen in dKO HSCs (Figure S2C). To examine whether the
reduction of antioxidant activity led to the alteration of the ROS
level inMax-null ESCs, we quantitated the ROS in cells via DCF-
DA fluorescence. BecauseMax-null ESCs cultured in the absence
of Dox express Max and Venus fluorescence protein (see Fig-
ure 1A) that perturbs quantitation of the ROS level, we eliminated
this expression from theROSA26 gene locus by treatingwith Dox,
but we introduced the indicated expression vector(s) or empty
vector randomly into the cell genome. As shown in Figure 2A,
we found that a high ROS level was indeed detected in Max-null
ESCs with the empty vector introduced, whereas the ROS level
declined significantly with forced expression of Max. We did not
observe an effect from coexpression of c-Myc and Max on the
ROS level compared with Max expression alone, although we
did observe a definite gene dosage effect when the cells were
subjected to a more rigorous condition, i.e., culture without
2-mercaptoethanol (2-ME) (Figure 2B). These results suggested
that the c-Myc/Max complex suppresses oxidative stress inCell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc. 39
AC
D
B
DCF-DA
Empty
Max
Max/MycWT
Max/MycT58A
-
-
+
-
+
-HA-cMycWT
FLAG-hMax
- - +HA-cMycT58A
c-Myc
Max
β-actin
+
+
-
8 yaD6 yaD4 yaD2 yaD
Myc
Core
Max KO ESCs (Dox treatment)
NES = 1.67
FDR q-value < 0.001 Leading Edge
R
O
S 
le
ve
ls
0
3
6
-
-
-
+ 2ME - 2ME
+
-
-
+
-
+
+
+
-
-
-
-
+
-
-
+
-
+
+
+
-
HA-cMycWT
FLAG-hMax
HA-cMycT58A
-1
-0.5
0
0.5
R
el
at
iv
e 
ex
pr
es
si
on
  v
al
ue
s 
(lo
g 2
)
Max KO ESCs HSCs
0 1 2 3 4 6 8 Contl dKO
Myc
Myc Leading Edge
Core
NES = -1.39
FDR q-value = 0.004
NES = -2.10
FDR q-value < 0.001
NES = -2.12
FDR q-value < 0.001
NES = 1.54
FDR q-value = 0.001
NES = -1.74
FDR q-value < 0.001
NES = -2.11
FDR q-value < 0.001
NES =  1.45
FDR q-value = 0.002
Figure 2. Alternation of ESC Gene Expression Programs after Max Gene Expression Ablation
(A) Quantification of intracellular ROS levels in Max-null ESCs transfected with the indicated expression plasmids via DCF-DA. Left panel shows Myc and Max
proteins detected by western blot analysis. The cMycT58A is a stabilized c-Myc protein that evades GSK-3b-mediated phosphorylation that is coupled with
proteolysis (Cartwright et al., 2005).
(B) Gene dosage effect of the c-Myc/Max complex on lowering the ROS level. Max-null ESCs transfected as in (A) were cultured in the presence or absence of
2-ME. Intracellular ROS levels were then quantitated with DCF-DA. The level of ROS observed with the cells in which Flag-tagged Max cDNA alone was
introduced (lane 2) was arbitrarily set to one. The data represent the mean with standard deviation (n = 3).
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Myc/Max Complex-Independent ESC Self-RenewalESCs and that apoptotic cell death observed withMax-null ESCs
is at least in part due to the elevated ROS.
Recently, Wong et al. (2008) identified a predominant gene
module with DNA microarray analyses, which was designated
the ESC-like module that is commonly activated in ESCs as well
as aggressive cancer cells. A recent report by Kim et al. (2010)
also highlights the importance of analyzing transcriptional regula-
tory subnetworks in ESCs. This involves the gene expression
signature of ESCs being dissected into three major functional
modules (Core, Polycomb, and Myc). Of note, the Myc module is
closely related to the core ESC-like module identified by Wong
et al. (2008) but is distinct from the Core module that comprises
genes regulated by core pluripotency factors such as Oct3/4
and Nanog. We monitored alterations of Myc and Core module
activities byGSEAduring lossofMaxgeneexpression (Figure 2C).
We found that the lossofMaxgeneexpression led toaprogressive
decline in Myc module activities, although a slight increase was
observed at day 2. We could also obtain similar results with the
ESC-like module (Figures S2D and S2E). In contrast, we found
the level of Core module activity was boosted for the first 4 days
after ablating Max gene expression. However, at 6 days post-
Dox addition, the level of Core module activity became negative
compared with the Dox-untreated cells, implying that Max-null
ESCs started to lose pluripotency. Although the decrease in
Core module activity inMax-null ESCs was preceded by a reduc-
tion of Myc module activity, we do not know at present whether
there is a functional link between thesemodules. As shown in Fig-
ure 2D, monitoring the changes in average expression levels of
these modules after ablating Max gene expression gave rise to
consistent results with GSEA shown in Figure 2C. We also calcu-
lated the average expression values of 206 genes representing
the leading edge of the Myc module that are responsible for the
decline in overall Myc module activity in Max-null ESCs at day 8
in GSEA (a list of individual gene names of this gene set is shown
inTable S2).We found that these genes showedamoreprominent
decline after ablating Max gene expression compared with total
Myc module genes (503 individual genes). GO analyses revealed
that genes involved in nucleic acid andmacromolecularmetabolic
processes and cellular process were remarkably enriched in Myc
module leading edge genes (Table S3). Although the question
remains whether or how these molecular functions are coupled
to the phenotypes observed withMax-null ESCs, we could spec-
ulate that ESCs produce substantial amounts of energy due to
these gene functions representing the metabolic processes to
support their robust growth and self-renewing properties.
Depletion of Max Gene Expression Is Accompanied by
Loss of the Undifferentiated State in ESCs through
Activation of MAPK Signaling
We next investigated whether the undifferentiated state of ESCs
was affected in the Max-null background. Semiquantitative(C) GSEA of Myc and Core modules in Max-null ESCs at the indicated days afte
references. Black bar in the lower right of the Myc module panel at day 8 repres
(D) The fold changes in Myc module genes (yellow) and Core module genes (pink
levels of Myc module leading edge genes (orange), which were selected by GSE
activity, are also shown. Data obtained with the corresponding gene set at day 0
dKO HSCs compared with those in wild-type HSCs are also shown.
See also Figure S2 and Tables S1–S3.RT-PCR analysis showed that there was no decline in the
mRNA levels for pluripotency markers such as Oct3/4 and
Nanog upon loss ofMax gene expression up to day 8 (Figure 3A).
However, the total Coremodule activity assessed byDNAmicro-
array analysis was eventually reduced inMax-null ESCs by day 6
(Figures 2C and 2D). This indicated that the overall activities of
these key pluripotency factors decreased in these cells. Consis-
tent with this assumption, western blotting revealed that the
Oct3/4, Sox2, and Nanog protein levels gradually declined
upon loss of Max gene expression (Figure 3B). Immunostaining
(Figure 3C) and FACS analyses (Figure 3D) revealed that Max-
null ESC colonies consisted of Oct3/4-positive and -negative
populations. This suggested that the decline in Oct3/4 levels
does not occur evenly, but occurs stochastically in the Max-
null ESC population when examined within a very short period.
Moreover, quantitative RT-PCR analysis of several lineage-
specificmarkers demonstrated that loss ofMax gene expression
resulted in the upregulation of endodermmarkers (Gata6, Gata4,
and Sox17), ectoderm markers (Fgf5, Sox1, Nestin, and Pax6),
and a trophectoderm marker (Cdx2), whereas mesoderm
markers (Brachyury and Desmin) were not induced (Figure 3E).
These results were not consistent with those obtained from
c-Myc/N-Myc dKO ESCs with these cells selectively differenti-
ating into primitive endoderm lineages (Smith et al., 2010).
Currently, we do not know why these phenotypic differences
occur. We also observed remarkably elevated levels of phos-
phorylated MAPK (ERK1/2) after Dox treatment (Figure 3F),
which were inversely correlated with Oct3/4 protein levels.
Because MAPK is known to destabilize the pluripotency of
mouse ESCs (Buecker et al., 2010; Kunath et al., 2007; Niwa
et al., 2009), we treatedMax-null ESCs with PD0325901, a small
molecule targetingMAPK kinase. This chemical treatment signif-
icantly blocked the decline of Oct3/4 and Sox2 and the emer-
gence of Oct3/4-negative cells after depletion of Max gene
expression (Figure 3G and 3H, also see Figure 4B). This implied
that MAPK activation was the primary cause of cellular differen-
tiation in Max-null ESCs. Also noteworthy is that PD0325901
treatment caused a tremendous decrease of the c-Myc protein
level irrespective of Dox treatment, whereas the protein levels
of other Myc members, i.e., N-Myc and L-Myc, and pluripotency
markers such as Oct3/4, Sox2, and Nanog were not affected by
PD0325901 alone (Figure 3G).
Hierarchical Relationship between the Loss of the
Undifferentiated State and Apoptotic Cell Death inMax-
Null ESCs
Although loss ofMax gene expression elevated several differen-
tiation markers, there were no surviving differentiated cells in the
presence of Dox. This indicated that the detrimental phenotype
persists in Max-null ESCs even after a differentiation program
is initiated. Consistent with this notion, our data showed thatr Dox administration with these modules in Dox-untreated Max-null ESCs as
ents the leading edge genes of the Myc module.
) are shown as the means with standard errors. The fold changes of expression
A shown in (C) as members responsible for the decline of overall Myc module
were used as references. The fold changes in these gene sets in c-Myc/N-Myc
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Figure 3. Gradual Loss of the Undifferentiated State of ESCs upon Max Expression Ablation
(A and B) Semiquantitative RT-PCR (A) and western blot analyses (B) of ESC markers, c-Myc, and Max in Max-null ESCs.
(C) Immunocytochemical analysis of Oct3/4 in Max-null ESCs treated with Dox for 6 days.
(D) FACS-based analysis of the Oct3/4-positive cell ratio upon the loss of Max expression. The data represent the mean with standard deviation (n = 3).
(E) Quantitative RT-PCR analysis of various cell-lineagemarker genes withMax-null ESCs treated with Dox for 6 days. The data represent the meanwith standard
deviation (n = 3). The value obtained from Dox-untreated cells was arbitrarily set to one.
(F) Inverse proportion between Phospho (Thr202, Tyr204)-ERK and Oct3/4 levels after ablating Max expression.
(G) Effect of PD0325901 on ESCmarkers andMyc proteins inMax-null cells.Max-null ESCs were treated with PD0325901 (PD03) or untreated () in the presence
or absence of Dox for 6 days.
(H) Effect of PD0325901 on the suppression of Oct3/4-negative cell emergence inMax-null ESCs.Max-null ESCs were treated as indicated for 6 days and then
subjected to immunocytochemical analysis to detect Oct3/4.
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Myc/Max Complex-Independent ESC Self-RenewalMax-null ESCs did not form embryoid bodies (Figure S3A) or
a teratoma (data not shown). These results promoted us to
explore the relationship between the loss of the undifferentiated
state and apoptotic cell death inMax-null ESCs. Coimmunocyto-
chemical analysis showed that the presence of Oct3/4 and acti-
vated Cas-3 was mutually exclusive (Figure 4A). Z-VAD-FMK
treatment suppressed the emergence of TUNEL-positive cells
(Figure 1G) but not the conversion of Oct3/4-positive to -nega-
tive cells (Figure 4B). On the other hand, PD0325901 treatment
prevented the emergence of Oct3/4-negative cells (Figure 4B)
and eliminated TUNEL-positive cells (Figure S3B). These results
indicate that loss of the undifferentiated state occurs first and is
followed by the induction of apoptosis and that MAPK activation42 Cell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc.is substantially involved in loss of the undifferentiated state of
Max-null ESCs. Western blot (Figure 4C) and FACS analyses
(Figure 4D) that examined activated Cas-3 levels and pluripo-
tency marker proteins supported this notion.
Forced Nanog Expression Renders Max Expression
Redundant in ESCs
Thus far, our analyses revealed that c-Myc/Max complex loss of
function in ESCs led to the loss of the undifferentiated state and
a subsequent reduction in cell viability. Therefore, we hypothe-
sized thatMax-null ESCs can indefinitely self-renew if the undif-
ferentiated state is maintained. To address this hypothesis, we
first overexpressed Oct3/4. However, this provoked extensive
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(A) Coimmunostaining of Oct3/4 and activated Cas-3 in Max-null ESCs treated with Dox for 6 days.
(B) Effects of Z-VAD-FMK or PD0325901 on the undifferentiated state.Max-null ESCswere treated as indicated for 6 days and then subjected to FACS analysis of
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See also Figure S3.
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demonstrating that expression level of Oct3/4 must be kept
within plus or minus 50% of the endogenous expression level
in order to maintain undifferentiated state of ESCs (Niwa et al.,
2000). Then, we overexpressed Klf4, Tbx3, and Nanog, which
allow ESCs to self-renew independently of LIF (Niwa et al.,
2009). Although Klf4 and Tbx3 expression did not affect Max-
null ESCs, forced Nanog expression prevented the decline in
Oct3/4 and Sox2 protein levels (Figure 5A) and produced viable
colonies (Figure 5B). TheNanog-expressingMax-null ESCswere
able to expand continuously even in the presence of Dox for at
least 3 months without any change in colony morphology. These
rescued cells were homogeneously positive for Oct3/4 andNanog (Figure 5C) and were TUNEL negative (Figure S4A).
Consistent results were obtained from western blot analysis
that examined the expression levels of pluripotency marker pro-
teins and activated Cas-3 (Figure 5D). Interestingly, expression
levels of c-Myc, N-Myc, and L-Myc in Nanog-rescued cells
was comparable to those in Dox-untreated cells, suggesting
that Nanog stabilizesMyc proteins free fromMax through a pres-
ently unknown mechanism. Cell proliferation rate (Figure 5E)
and cell cycle (Figure 5F) analyses indicated that the defects
observed with Dox-treated cells were completely eliminated by
forced Nanog expression. Collectively, these results indicated
that forced Nanog expression rendersMax expression dispens-
able for the unlimited self-renewal of ESCs. We also examinedCell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc. 43
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Figure 5. Forced Nanog Expression Results in the Long-Term Preservation of ESC Self-Renewal in the Absence of Max Expression
(A)Max-null ESCs were stably transfected with expression vectors encoding KLF4, Tbx3, wild-type (WT), or a caspase-resistant mutant (D67G) of Nanog. After
Dox treatment for 6 days, cell lysates were prepared and subjected to western blot analysis with the indicated antibodies.
(B) Microscopy inspection of Nanog-rescued cells.
(C) Immunocytochemical analysis of Oct3/4 and Nanog in Nanog-rescued cells.
(D) Western blot analysis of ESC markers, Myc family proteins, and activated Cas-3 in Nanog-rescued cells.
(E) The proliferation rate ofNanog-rescued cells. Ten thousand respective stable cells were plated and the total cell number was counted 4 days after treatingwith
Dox. The data represent the mean with standard deviation (n = 3).
(F) Cell cycle analysis of Nanog-rescued cells by FACS. The data represent the mean with standard deviation (n = 3).
(G) Myc and Core module activities in Nanog-rescued Max-null ESCs. Data were obtained as in Figure 2B.
See also Figure S4.
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Myc/Max Complex-Independent ESC Self-Renewalthe ability of a modified form of Nanog, D67G, which is resistant
to caspase-mediated cleavage (Fujita et al., 2008), to impact the
self-renewal of ESCs. However, we did not detect any differ-
ences between wild-type Nanog and the D67G mutant to coun-44 Cell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc.teract the loss of pluripotency and impaired cell viability (Figures
5B–5F). This finding reinforced the notion that there is a hierar-
chical order in the loss of the undifferentiated state and cell
viability in Max-null ESCs in which the caspase-dependent
Cell Stem Cell
Myc/Max Complex-Independent ESC Self-Renewalapoptosis pathway is initiated only after loss of the undifferenti-
ated state. We examined whether expression of RNA poly-
merase III (Pol III) target genes was normal or affected in Max-
null ESCs and Nanog-rescued cells, because Myc is known
to support transcription of these genes independently of Max
(Gomez-Roman et al., 2003; Steiger et al., 2008). RT-PCR anal-
ysis revealed that both Nanog-rescued and Dox-treated Max-
null ESCs, which maintain normal and reduced levels of Myc
proteins, respectively, supported normal levels of expression
for all Pol III target genes examined (Figures S4B and S4C).
These results implied that a low Myc protein level in Dox-treated
cells was enough to support Pol III target gene expression. Alter-
natively, certain compensatory mechanisms may have been
operative in these cells.
We next examined how forced Nanog expression affects the
level of Myc and Core module activities in the rescued Max-
null ESCs (Figure 5G). As shown in Figure 2D, both module activ-
ities in Max-null ESCs were significantly impaired by Dox treat-
ment for more than 6 days. However, we found that no decline
in Core module activity became evident in Nanog-rescued cells.
Unexpectedly,Max-null ESCs also regainedMycmodule activity
to a normal level with forced Nanog expression. However, the
average expression values of genes comprising the leading
edge of the module remained below that of Dox-untreated
Max-null ESCs. This implied that Nanog did not fully engage in
restoring the Myc module program to the original state as
observed with Dox-untreated Max-null ESCs. However, Nanog
did somehow boost the average module activity through
a distinct pathway from that of Myc/Max complexes.
The 2i Condition Renders Myc/Max Complexes
Dispensable in ESCs
We found that PD0325901 counteracted the strong negative
effect of Max gene expression ablation on the preservation of
the undifferentiated state and cell viability (see Figure 4B and
Figure S3B as references). However, the rescue effect of
PD0325901 was not complete and loss of the undifferentiated
state and cell death became prominent after several passages
(data not shown). Recently reported is that c-Myc gene expres-
sion levels are unusually low when ESCs are exposed to a so-
called ground state or related condition via PD0325901 and
CHIR99021, a specific GSK-3b inhibitor, i.e., the 2i condition
(Ying et al., 2008). Therefore, we hypothesized that the 2i condi-
tion preserves the ESC status without using Myc/Max transcrip-
tional complexes. To test this hypothesis, we cultured Max-null
ESCs with PD0325901 and CHIR99021 in the presence of Dox.
We found that the 2i condition almost completely rescued
Max-null ESCs (Figure 6A) and the colonies could be passaged
at least 30 times with no change in morphology compared
with Max-null ESCs that were not Dox treated, although the
2i-rescued cells did have a slightly slower proliferation rate. We
next added a sirt1 inhibitor, nicotinamide (Nam) (Chong et al.,
2005), while the cells were being treated with the 2i condition
because our data revealed that sirt1 is substantially involved in
Max-null ESC apoptosis (T.H. and A.O., unpublished data). We
found that the 2i/Nam condition rendered Dox-treated Max-null
ESCs completely indistinguishable from untreated cells, even
with respect to the proliferation rate. Figure 6B shows the homo-
geneous expression of Oct3/4 and Nanog in cells that wererescued with 2i or 2i/Nam. Western blot analysis (Figure S5A)
revealed that the expression levels of pluripotency markers,
including Tbx3 and Klf4, in the rescued cells were comparable
with control Dox-untreated Max-null ESCs. The activated Cas-3
level in Max-null ESCs also concomitantly declined because of
the 2i and 2i/Nam treatments.
To rule out the possibility that the rescue effect of the 2i treat-
ment depended on ‘‘leaky’’ Max gene expression from the
ROSA26 locus, which can be detected even with Dox, we gener-
ated three independent ESC clones (clone 31, 32, and 35) in
which a Dox-regulatable Max expression unit is removed from
the locus, while the cells were exposed to 2i condition (see Fig-
ure S5B for strategy). Lack of Max protein and of the gene
expression were confirmed by western blot (Figure 6C) and
Southern blot (Figure S5B) analyses, respectively. These strictly
Max-null ESCs could be expanded while maintaining their ESC
status (see Figure S5C and Figure 6C for their viability and
Oct3/4 expression, respectively). However, these cells under-
went extensive cell death irrespective of Dox absence when
transferred to empirical culture conditions for mouse ESCs (Fig-
ure S5C). Thus, these results further reinforced the context-
dependent requirement of Myc/Max complexes to preserve
the undifferentiated state of ESCs.
To test whether the 2i/Nam-rescued cells could re-enter
embryonic development once Max expression was regained,
Max-null ESCs bearing Dox-regulatable Max cDNA and the
strictly Max-null clone 31 were labeled with fluorescent Kusa-
bira-Orange protein under the 2i/Nam condition. Subsequently,
these cells were subjected to mouse chimera analysis. Although
we observed a minor contribution from the strictlyMax-null cells
in one out of six 6.5 d.p.c. embryos (Figure S5D and Table S4),
these cells failed to contribute to embryos at later stages (Fig-
ure 6D and Table S4). These results were consistent with the
embryonic lethal phenotype of the Max knockout mouse at
E6.5 (Shen-Li et al., 2000). However, Max-null ESCs carrying
Dox-regulatable Max cDNA contributed to the entire epiblast
portion of 6.5 d.p.c. embryos (Figure S5D) and to all three
germ layers of 9.5 d.p.c. embryos (Figure 6D), although these
levels of contribution from the embryo-injected cells progres-
sively declined after E10.5 (see Table S4). These results indicate
thatMax-null ESCs maintained in the 2i/Nam plus Dox condition
at least preserve all of requirements to differentiate into deriva-
tives of all three germ layers during mouse development except
the Max protein. However, our data also indicate that these cells
are not completely equivalent to wild-type ESCs and show
some defect in their pluripotency even if Max expression is
complemented.
Next, we investigated the effect ofMax gene expression abla-
tion on gene expression profiles of ESCs cultured under 2i/Nam
condition. We found that a substantial number of genes showed
significant differences in their expression levels between wild-
type and strictly Max-null ESCs cultured under 2i/Nam condi-
tions, although the variable levels were significantly less promi-
nent compared to the case with a conventional culture condition
(Figure S6A). Alteration of gene expression between these two
cell populations under 2i/Nam condition was also shown with
a heat map (Figure S6B). We assume that some of the genes
identified in these analyses may be responsible for some defect
of 2i/Nam-rescued Max-null ESCs in their pluripotency, whichCell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc. 45
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Figure 6. The 2i Condition Preserves the ESC Status through a Myc/Max Complex-Independent Mechanism
(A) Treating with 2i or 2i/Nam erased the lethal phenotype of Max-null ESCs. Cell viability was examined as in Figure 1C with Max-null ESCs treated with 2i or
2i/Nam.
(B) Immunostaining analysis of Oct3/4 and Nanog in 2i- and 2i/Nam-rescued cells.
(C) Western blot analysis of ESC markers and Myc family proteins in wild-type and strictly Max-null ESCs with the Dox-regulatable Max expression unit in the
ROSA26 gene locus removed under 2i/Nam conditions.
(D) Chimeric mouse analysis. Fluorescent Kusabira-Orange protein-labeledMax-null ESCs with or without a Dox-regulatableMax expression unit were injected
into blastocysts. Embryos were allowed to develop in recipient female mice. Fluorescent and bright-field images of embryos recovered at E9.5 are shown. The
rescued Max-null ESCs with 2i produced equivalent results (see Table S4).
(E) Myc and Core module activities in wild-type and strictlyMax-null ESCs cultured under the 2i/Nam condition. The fold change of each gene set was calculated
and shown as the means with standard errors. Data obtained with the corresponding gene set of the wild-type ESCs (WT) cultured under 2i/Nam condition were
used as references.
See also Figures S5 and S6 and Table S4.
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Myc/Max Complex-Independent ESC Self-Renewalbecame evident with chimeric mouse analyses (Figure 6D and
Table S4). Because two of Myc module members were included
in the gene list which declined their expression more than 4-fold
(Figure S6B), we next examined the Myc module activity. This
analysis revealed that the module activity was significantly
declined in strictly Max-null ESCs compared to that of wild-
type ESCs even under the 2i/Nam condition (Figure 6E). Since
c-Myc expression was barely detectable in the 2i/Nam condition
(see Figure 6C), other Myc protein members, i.e., N-Myc and
L-Myc, may contribute to Myc module activity in wild-type
ESCs for this condition. More importantly, strictly Max-null
ESC lines had Core module activity comparable with that of
wild-type ESCs (Figure 6E). Data from GSEA supported this
notion (Figure S6C). Thus, these data indicated that, unlike
ESCs cultured under a conventional culture condition, decline46 Cell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc.of Myc module activity does not couple to the impairment of
Core module activity and, therefore, provide additional evidence
that the 2i condition can preserve the ESC status independently
of Myc/Max transcriptional complexes.
DISCUSSION
Accumulating evidence has placed c-Myc at the heart of the
regulatory network that governs the undifferentiated state of
ESCs (Cartwright et al., 2005; Hu et al., 2009; Singh and Dalton,
2009; Smith et al., 2010; Varlakhanova et al., 2010). Recently
discovered was that c-Myc regulates the mir-17-92 miRNA to
create the typical ESC cycle profile and repressesGata6 expres-
sion to prevent cellular differentiation. However, numerous key
questions remain unanswered. For example, it was not known
FGF-4 pERK
c-Myc
LIF
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c-Myc
c-Myc
Loss of undifferentiated state Differentiation
Cell death
Activation of caspase pathwayMax
P
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Figure 7. Proposed Model of the c-Myc/Max Complex Functions that Maintain the Pluripotent State of ESCs
c-Myc mRNA levels are transcriptionally boosted by LIF signaling through the JAK-STAT3 pathway, while the c-Myc protein is stabilized by pERK-mediated
phosphorylation. The c-Myc/Max complex supports the self-renewal of pluripotent ESCs by inhibiting MAPK signaling that is activated by LIF and FGF and
negatively affects the pluripotent state of ESCs. The complex also directly suppressesGata6 gene expression to prevent differentiation, demonstrated by Smith
et al. (2010). Another role of c-Myc/Max is to support the viability of cells that have lost the undifferentiated state.
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Myc/Max Complex-Independent ESC Self-Renewalwhether the requirement of c-Myc/Max is absolute for preserving
the remarkable properties of ESCs in any culture condition.
Here, we report the establishment of Max-null ESCs and
demonstrate that Max gene expression ablation in an empirical
culture condition induces a loss of the undifferentiated state
and caspase-dependent cell death in that order. This hierarchy
possibly also occurs in cancer stem cells, as indicated by the
fact that the Max-null condition in ESCs leads to impairment of
the Myc module and ESC-like gene expression programs that
are commonly activated in ESCs and cancer stem cells in
a Myc-dependent manner (Kim et al., 2010; Wong et al., 2008).
Therefore, we could speculate that our findings may lead to
a new cancer therapy that eradicates cancer stem cells by im-
pairing the Myc-dependent undifferentiated state. It will be
important to determine whether this rule is restrictively enforced
in Max-null ESCs or if this is the general death mechanism in
ESCs. Although Max-null ESCs undergo extensive cell death,
c-Myc/N-Myc dKO ESCs are viable, but these cells fail to
preserve a pluripotent state. One explanation is that L-Mycmight
be responsible for the differences in phenotype and cell viability
due to functional L-Myc being in dKO ESCs but not in Max-null
ESCs. However, unlike c-MycRX (a mutant used in Figure 1I),
the corresponding L-Myc mutant, L-MycRX, could not exhibit
any noticeable effect on either pluripotency or cell viability of
Max-null ESCs with MaxRX (data not shown). The pheochromo-
cytoma cell line PC12 bears no functional Max protein because
of a homozygous gene mutation. Notwithstanding, forced
expression of c-Myc induces extensive cell death (Wert et al.,
2001). Therefore, the same mechanism possibly operates in
Max-null ESCs.
One of the important findings of our study is that the c-Myc/
Max complex in ESCs suppresses ERK signaling as well as
Gata6 expression (Smith et al., 2010) to prevent ESC differentia-
tion. MAPK phosphorylates c-Myc at Ser62, leading to the stabi-lization of the c-Myc protein (Lee et al., 2008; Sears et al., 2000).
In agreement with the previous observation (Ying et al., 2008),
our analyses revealed that PD0325901 treatment profoundly
reduced c-Myc protein levels in ESCs (Figure 3G), indicating
that MAPK-dependent stabilization of the c-Myc protein also
occurs in ESCs. Based on our findings and previous reports
from other groups (Cartwright et al., 2005; Smith et al., 2010;
Ying et al., 2008), we propose a hierarchical model depicted in
Figure 7. In this model, the c-Myc gene is induced by LIF via
STAT3 signaling and the resulting c-Myc protein is stabilized
via MAPK signaling activated by FGF and/or LIF. The stabilized
c-Myc protein then suppresses MAPK signaling to prevent
ESC differentiation, although the molecular basis of this
suppression is not currently known.
Finally, our data demonstrate that the c-Myc/Max complex is
dispensable for preserving the ESC status when exposed to the
2i condition. This finding is somewhat surprising because the
c-Myc/Max complex, like Oct3/4, is widely regarded as a crucial
regulator for sustaining the ESC status (Cartwright et al., 2005;
Hu et al., 2009; Singh and Dalton, 2009; Smith et al., 2010; Var-
lakhanova et al., 2010). We found that, like the 2i condition,
forced Nanog expression also conferred unlimited ESC self-
renewal in the absence of Myc/Max complexes. However, there
is a significant difference between these two rescues, with
Nanog expression boosting Myc module activity and Core
module activity to the normal levels, while the 2i condition
rescued Max-null ESCs without significantly affecting Myc
module activity.
Empirical culture medium containing LIF and serum to sustain
the ESC status is only effective with a few specific inbred mouse
strains such as the 129 line, but not for rat andmost other mouse
ESC lines (Buehr et al., 2008; Hanna et al., 2009; Li et al., 2008).
However, the application of 2i or related conditions appears to
be much broader than conventional culture condition with LIFCell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc. 47
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Myc/Max Complex-Independent ESC Self-Renewaland serum. Indeed, it has been reported that self-renewal and
pluripotency can be permanently maintained in cells from rats
and nonobese diabetic mice (Buehr et al., 2008; Hanna et al.,
2009; Li et al., 2008). Therefore, our data raises an interesting
possibility that a wider application of 2i or related conditions
compared with empirical culture conditions may be attributable
to the independence of Myc/Max transcriptional complexes to
preserve the ESC status.
EXPERIMENTAL PROCEDURES
Plasmid Constructions
For tet-off expression of theMax gene,Max cDNAwas subcloned into theXhoI/
NotI sites of the exchange vector pZhCSfi (Masui et al., 2005). For pCAG-IH-
HA-cMycWT, pCAG-IH-HA-c-MycEG, pCAG-IH-HA-c-MycRX, pCAG-IP-
FLAG-MaxWT, pCAG-IP-FLAG-MaxEG, and pCAG-IP-FLAG-MaxRX, the
ORFs for the wild-type, EG mutant, and RX mutant of c-Myc and Max were
PCR amplified from the corresponding cDNA-containing plasmids provided
by Dr. Bruno Amati. For pCAG-IP-NanogWT and pCAG-IP-KLF4, PCR-ampli-
fied ORFs for Nanog and KLF4 by means of total RNA from mouse ESCs were
sequenced and subcloned into pCAG-IP (Niwa et al., 2002) or pCAG-IH, which
conferred puromycin or hygromycin resistance, respectively. Mouse
NanogD67G mutagenesis was performed with Pfu and DpnI.
A targeting vector for theMax gene was designed to replace exons 3, 4, and
5 that encode from the 21st amino acid onward and contains the entire basic
DNA-binding region and HLH-Z domain, with a b-galactosidase/neomycin-
resistance gene (b-geo). To construct a targeting vector for the Max gene,
the 50 and 30 homologous arms were PCR amplified with BAC DNA carrying
the entire Max gene (RP23-246K11) as a template. These homologous arms
were introduced into a Bluescript-based vector containing a negative selection
marker, diphtheria toxin A subunit (DTA), together with the b-geo reporter gene.
ESC Culture and Transfection
EBRTcH3 ESCs (Masui et al., 2005) and their derivatives were cultured via
standardmedium containing fetal bovine serum (FBS) and LIF unless indicated
otherwise. Expression plasmids were transfected into ESCs with a Nucleofec-
tor (Lonza). The expression plasmids (5 mg) were introduced with the A-23
Nucleofector program.
Cell Cycle Analysis
BrdU labeling was performed with anti-BrdU according to the manufacturer’s
instructions. The labeled cells were stained with propidium iodide (PI) and
analyzed on a FACS Calibur flow cytometer with doublet discrimination. The
data were analyzed with CellQuest software from Becton Dickinson.
Detection of Intracellular ROS
ROS levels were determined by incubating cells with 10 mMDCF-DA for 30min
at 37C in thepresence of 20mMverapamil. Thecellswerewashed twice inPBS
and then trypsinized. Fluorescence was measured with the flow cytometer.
Blastocyst Injection
2i/Nam-rescuedMax-null ESCs bearing Dox-regulatableMax cDNA and those
lacking the cDNA were labeled with fluorescent Kusabira-Orange protein.
These labeled cells were injected into blastocysts and transferred into
surrogate C57BL/6 mice. Embryos at E6.5 and E9.5 were recovered and
inspected by microscopy.
Microarray Analysis
Biotin-labeled cRNA synthesized according to the Affymetrix guidelines were
hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 arrays. For scan-
ning and intensity data analyses, see Supplemental Experimental Procedures.
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DNA microarray data are deposited in NCBI’s Gene Expression Omnibus
under accession number GSE27881.48 Cell Stem Cell 9, 37–49, July 8, 2011 ª2011 Elsevier Inc.SUPPLEMENTAL INFORMATION
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